本文關鍵詞： 缺氧誘導因子-α 程序性死亡因子配體 肺腺癌　出處：《山東大學學報(醫(yī)學版)》2017年04期 　論文類型：期刊論文

【摘要】：目的研究缺氧誘導因子-1α(HIF-1α)和程序性死亡因子配體1(PD-L1)在肺腺癌中的表達與臨床病理特征的關系,探討肺腺癌中HIF-1α對PD-L1的調控作用。方法應用免疫組織化學方法檢測99例肺腺癌組織中HIF-1α、PD-L1的表達。Co Cl2模擬化學性缺氧處理肺腺癌細胞,并將其分為正常組及CoCl_2組,qRT-PCR檢測HIF-1α、PD-L1 mRNA表達,Western blotting檢測HIF-1α、PD-L1蛋白表達。siRNA-HIF-1α瞬時轉染肺腺癌細胞,并將其分為陰性對照組及siR-HIF-1α組,qRT-PCR、Western blotting檢測轉染效率及PD-L1 mRNA和蛋白的表達。結果 99例肺腺癌組織中,HIF-1α和PD-L1的陽性率分別為47.48%和34.34%,HIF-1α表達水平與患者年齡和臨床分期有關(P0.05),PD-L1表達水平與患者臨床分期有關(P0.05),HIF-1α蛋白表達與PD-L1蛋白表達呈正相關(P0.01)。與正常組相比,CoCl_2組細胞中HIF-1α蛋白表達水平明顯升高(t=-2.394,P=0.029),PD-L1 mRNA及蛋白表達水平隨之明顯升高(t=-3.146,P=0.006;t=-3.308,P=0.004)。與陰性對照組相比,siR-HIF-1α組沉默處理細胞后,PD-L1 mRNA及蛋白表達水平顯著降低(t=2.746,P=0.014;t=2.339,P=0.033)。結論肺腺癌組織中HIF-1α和PD-L1明顯共表達;PD-L1表達受HIF-1α調控。
[Abstract]:Objective to study the relationship between the expression of hypoxia inducible factor-1 偽 (HIF-1 偽) and programmed death factor ligands 1 (PD-L1) in lung adenocarcinoma and the clinicopathological features. To investigate the regulatory effect of HIF-1 偽 on PD-L1 in lung adenocarcinoma. Methods the expression of HIF-1 偽 PD-L1 in 99 cases of lung adenocarcinoma was detected by immunohistochemical method. The expression of PD-L1 in 99 cases of lung adenocarcinoma was treated with simulated chemical hypoxia. It was divided into two groups: normal group and CoCl_2 group. The expression of HIF-1 偽 -PD-L1 mRNA was detected by qRT-PCR. Western blotting was used to detect the expression of HIF-1 偽 -pPD-L1 protein. SiRNA-HIF-1 偽 was transiently transfected into lung adenocarcinoma cells. The efficiency of transfection and the expression of PD-L1 mRNA and protein in 99 cases of lung adenocarcinoma were detected by Western blotting. Results the positive rates of HIF-1 偽 and PD-L1 in 99 cases of lung adenocarcinoma were 47.48% and 34.34%, respectively, and the expression levels of HIF-1 偽 were correlated with the age and clinical stage of the patients. There was a positive correlation between the expression of P0.05HIF-1 偽 protein and the expression of PD-L1 protein. Compared with the normal group, the expression level of HIF-1 偽 protein in the cells of CoCl2 group was significantly higher than that in the normal group. The expression level of PD-L1 mRNA and protein increased significantly. Compared with control group, the expression of PD-L1 mRNA and protein in the silenced cells of the negative control group was significantly lower than that in the control group. Conclusion the expression of HIF-1 偽 and PD-L1 in lung adenocarcinoma is regulated by HIF-1 偽.
【作者單位】： 山東大學附屬省立醫(yī)院檢驗部;
【基金】：國家自然科學基金(81372775) 山東省醫(yī)藥衛(wèi)生科技發(fā)展計劃(2014WS0076)
【分類號】：R734.2

【相似文獻】

相關期刊論文 前10條

1 楊晉平,王澤,張?zhí)K;肺腺癌5-羥色胺受體的免疫組織化學定位[J];四川解剖學雜志;2003年02期

2 吳一龍,林嘉穎,楊學寧,喬貴賓,王坤,陳剛;肺腺癌患者酪氨酸激酶信號傳導通路的異常與臨床預后[J];中華醫(yī)學雜志;2004年12期

3 張利群,陳杭薇,王四海,辛慶紅,杜玉國,尤蘭華;人呼吸道合胞病毒轉錄調節(jié)基因轉染肺腺癌細胞系的研究[J];山東醫(yī)藥;2005年12期

4 黎聯(lián);梅同華;周向東;張新高;車德亞;;細胞外信號調節(jié)激酶信號通路與基質金屬蛋白酶-26在肺腺癌表達中的關系[J];第三軍醫(yī)大學學報;2009年02期

5 王亞南;顧國浩;;生物芯片在肺腺癌研究和診療中的應用進展[J];國際檢驗醫(yī)學雜志;2011年02期

6 ;我國人體肺腺癌細胞系建立[J];腫瘤;1981年06期

7 季晨陽,張義R，

本文編號：1523811